[ Price : $8.95]
FDA's Gastroenterology and Urology Devices Panel votes to recommend wider use for Allergan's LAP-Band System for weight reduction ...[ Price : $8.95]
In a new Columbia Journalism Review article, FDA Webview editor Jim Dickinson tells how government press officers stole our freedo...[ Price : $8.95]
DDMAC says Allergan should stop using a Lumigan mailer directed at healthcare professionals because it allegedly contains unsubsta...[ Price : $8.95]
Seattle Genetics says it plans a first quarter 2011 BLA for brentuximab vedotin (SGN-35) for treating relapsed or refractory Hodgk...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on requirements for persons exporting products that may not be marketed in the U.S.[ Price : $8.95]
Federal Register Notice: FDA sends to the Office of Management and Budget and releases a guidance: Use of Serological Tests to Red...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Bausch & Lombs Besivance for the purpose of patent extens...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Centocor Ortho Biotechs Stelara for the purpose of patent...